Engineering of the gut commensal bacterium Bacteroides ovatus to produce and secrete biologically active murine interleukin‐2 in response to xylan

Aims:  The aim of this work was to engineer a gut commensal bacterium, Bacteroidesovatus, to produce and secrete a biologically active cytokine in a regulated manner as a basis for novel immunotherapies for chronic gut disorders.

[1]  C. Webb,et al.  Application of cereals and cereal components in functional foods: a review. , 2002, International journal of food microbiology.

[2]  L. Steidler,et al.  Microbiological and immunological strategies for treatment of inflammatory bowel disease. , 2001, Microbes and infection.

[3]  F. Shanahan,et al.  Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. , 2001, Gastroenterology.

[4]  W. Fiers,et al.  Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. , 2000, Science.

[5]  F. Cominelli,et al.  Discovering the cause of inflammatory bowel disease: lessons from animal models. , 2000, Current opinion in gastroenterology.

[6]  R. Blumberg,et al.  Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. , 1999, Current opinion in immunology.

[7]  G. D'Haens,et al.  Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. , 1999, Gastroenterology.

[8]  E. Remaut,et al.  Mucosal Delivery of Murine Interleukin-2 (IL-2) and IL-6 by Recombinant Strains of Lactococcus lactis Coexpressing Antigen and Cytokine , 1998, Infection and Immunity.

[9]  S. Targan,et al.  A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease , 1997 .

[10]  C. Elson,et al.  Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. , 1997, Gastroenterology.

[11]  D. Hommes,et al.  Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). , 1995, Gastroenterology.

[12]  W. Fiers,et al.  Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis , 1995, Applied and environmental microbiology.

[13]  A. Feller,et al.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.

[14]  S. Tonegawa,et al.  Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice , 1993, Cell.

[15]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[16]  M. Sporn,et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Feldhaus,et al.  Location and characterization of genes involved in binding of starch to the surface of Bacteroides thetaiotaomicron , 1992, Journal of bacteriology.

[18]  M. Cotta,et al.  Genetic analysis of a locus on the Bacteroides ovatus chromosome which contains xylan utilization genes , 1992, Applied and environmental microbiology.

[19]  A. Salyers,et al.  Cloning and partial characterization of two chromosomal loci from Bacteroides ovatus that contain genes essential for growth on guar gum , 1992, Applied and environmental microbiology.

[20]  R. B. Hespell,et al.  Purification and Characterization of an α-l-Arabinofuranosidase from Butyrivibrio fibrisolvens GS113 , 1992, Applied and environmental microbiology.

[21]  R. B. Hespell,et al.  The genes for three xylan-degrading activities from Bacteroides ovatus are clustered in a 3.8-kilobase region , 1990, Journal of bacteriology.

[22]  D. Savage.  The Normal Human Microflora-Composition , 1989 .

[23]  M. Sporn,et al.  Transforming Growth Factor , 1990 .

[24]  R. Derynck,et al.  Transforming growth factor α , 1988, Cell.

[25]  R. B. Hespell,et al.  Fermentation of xylans by Butyrivibrio fibrisolvens and other ruminal bacteria , 1987, Applied and environmental microbiology.

[26]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[27]  D. Hanahan.  Studies on transformation of Escherichia coli with plasmids. , 1983, Journal of molecular biology.

[28]  Kendall A. Smith,et al.  T cell growth factor: parameters of production and a quantitative microassay for activity. , 1978, Journal of immunology.